JeNaCell
GermanyWho owns JeNaCell?
JeNaCell is a German Biotech company, now owned by Evonik Industries, which acquired it in 2021 from High-Tech Gruenderfonds (HTGF), Evonik Venture Capital and bm-t Beteiligungsmanagement Thueringen.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
- ·Fully exited in 2021 to Evonik.
- ·Average hold across 3 realized cycles: 7 years.
Ownership history
3 ownership periods · co-invest detected
High-Tech Gruenderfonds (HTGF) sold JeNaCell to Evonik in 2021 after 9 years.
bm-t Beteiligungsmanagement Thueringen sold JeNaCell to Evonik Industries in 2021 after 6 years.
Evonik Venture Capital sold JeNaCell to Evonik Industries in 2021 after 6 years.
More from Thueringer WachstumsBeteiligungsFonds (WBF)
Other portfolio companies in the same fund.
More bm-t Beteiligungsmanagement Thueringen portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns JeNaCell?
JeNaCell is now owned by Evonik Industries, which acquired it in 2021 from High-Tech Gruenderfonds (HTGF), Evonik Venture Capital and bm-t Beteiligungsmanagement Thueringen.
When did Evonik Industries acquire JeNaCell?
Evonik Industries acquired JeNaCell in 2021, buying from High-Tech Gruenderfonds (HTGF), Evonik Venture Capital and bm-t Beteiligungsmanagement Thueringen.
Who did JeNaCell sell to?
High-Tech Gruenderfonds (HTGF) sold JeNaCell to Evonik in 2021 (Trade Sale). Evonik Venture Capital and bm-t Beteiligungsmanagement Thueringen sold JeNaCell to Evonik Industries in 2021 (Trade Sale).
Who has owned JeNaCell over time?
JeNaCell has been through 3 private-equity ownership periods: High-Tech Gruenderfonds (HTGF) · via HTGF II · 2012–2021 · sold to Evonik · (Trade Sale); Evonik Venture Capital · via Evonik Venture Capital · 2015–2021 · sold to Evonik Industries · (Trade Sale); bm-t Beteiligungsmanagement Thueringen · via Thueringer WachstumsBeteiligungsFonds (WBF) · 2015–2021 · sold to Evonik Industries · (Trade Sale).